×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
Nasdaq
DURECT Corporation today announced financial results for the three months ended March 31, 2024 and provided a business update. During a Type C meeting with...
1 day ago
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
Yahoo Finance
DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform...
2 weeks ago
Durect Enters Co-Marketing & Collaboration Agreement with Charles River Laboratories
Contract Pharma
Durect Corporation, has entered into a co-marketing and collaboration agreement with Charles River Laboratories, a global provider of drug...
1 month ago
Durect: Q1 Earnings Snapshot
Houston Chronicle
CUPERTINO, Calif. (AP) — CUPERTINO, Calif. (AP) — Durect Corp. (DRRX) on Monday reported a loss of $7.6 million in its first quarter.
1 week ago
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PR Newswire
PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and year ended December 31,...
1 month ago
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates
Yahoo Finance
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates ... In this article: DRRX. Durect (DRRX) came out with a quarterly loss of $0.27 per share...
1 month ago
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM ...
PR Newswire
PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies...
3 weeks ago
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
PR Newswire
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update. DURECT Corporation (Nasdaq:...
6 months ago
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated ...
PR Newswire
"The topline results from AHFIRM provide compelling evidence that administration of larsucosterol can reduce mortality at 90 days in this...
6 months ago
Q2 2024 EPS Estimates for DURECT Co. Lifted by Analyst (NASDAQ:DRRX)
Defense World
DURECT Co. (NASDAQ:DRRX – Free Report) – Equities researchers at HC Wainwright raised their Q2 2024 EPS estimates for shares of DURECT in a...
3 days ago